(Q57983933)

English

Antioxidative strategies in cognitive impairment: a novel connection between biliverdin-reductase and statins

No description defined

In more languages

edit

Statements

0 references

0 references

Antioxidative strategies in cognitive impairment: a novel connection between biliverdin-reductase and statins (English)

0 references

main subject

cognitive dysfunction

1 reference

Mikael Simons

2

0 references

author name string

Anja Schneider

series ordinal

1

0 references

language of work or name

English

0 references

publication date

14 December 2011

0 references

published in

Journal of Neurochemistry

0 references

volume

120

0 references

issue

1

0 references

page(s)

1-3

0 references

cites work

Pharmacological and clinical aspects of heme oxygenase

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07548.X

retrieved

21 January 2018

Biliverdin reductase--a protein levels and activity in the brains of subjects with Alzheimer disease and mild cognitive impairment.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07548.X

retrieved

21 January 2018

Biliverdin reductase-A: a novel drug target for atorvastatin in a dog pre-clinical model of Alzheimer disease.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07548.X

retrieved

21 January 2018

Atorvastatin treatment in a dog preclinical model of Alzheimer's disease leads to up-regulation of haem oxygenase-1 and is associated with reduced oxidative stress in brain.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07548.X

retrieved

21 January 2018

Use of statins and incidence of dementia and cognitive impairment without dementia in a cohort study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07548.X

retrieved

21 January 2018

Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam Study.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07548.X

retrieved

21 January 2018

Simvastatin-induced heme oxygenase-1 increases apoptosis of Neuro 2A cells in response to glucose deprivation

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07548.X

retrieved

21 January 2018

Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07548.X

retrieved

21 January 2018

Pyrazole induced oxidative liver injury independent of CYP2E1/2A5 induction due to Nrf2 deficiency

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07548.X

retrieved

21 January 2018

Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07548.X

retrieved

21 January 2018

A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07548.X

retrieved

21 January 2018

Simvastatin prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced striatal dopamine depletion and protein tyrosine nitration in mice

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07548.X

retrieved

21 January 2018

Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease: A 26-week randomized, placebo-controlled, double-blind trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07548.X

retrieved

21 January 2018

Reduced risk of incident AD with elective statin use in a clinical trial cohort

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07548.X

retrieved

21 January 2018

Identifiers

DOI

10.1111/J.1471-4159.2011.07548.X

0 references

PubMed publication ID

22017407

0 references

(Q57983933)

Antioxidative strategies in cognitive impairment: a novel connection between biliverdin-reductase and statins

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)